idasanutlin
Showing 1 - 13 of 13
Rhabdoid Tumor, Atypical Teratoid/Rhabdoid Tumor, Atypical Teratoid/Rhabdoid Tumor of CNS Trial in Memphis (Idasanutlin,
Not yet recruiting
- Rhabdoid Tumor
- +3 more
- Idasanutlin
- Selinexor
-
Memphis, TennesseeSt. Jude Children's Research Hospital
Jul 11, 2023
Acute Myeloid Leukemia (AML), Acute Lymphoblastic Leukemia (ALL), Neuroblastoma Trial in Worldwide (Idasanutlin, Venetoclax,
Recruiting
- Acute Myeloid Leukemia (AML)
- +3 more
- Idasanutlin
- +6 more
-
Phoenix, Arizona
- +19 more
Jan 18, 2023
Follicular Lymphoma, Lymphoma, Large B-Cell, Diffuse Trial in Worldwide (Idasanutlin, Obinutuzumab, Venetoclax)
Terminated
- Follicular Lymphoma
- Lymphoma, Large B-Cell, Diffuse
- Idasanutlin
- +3 more
-
Aurora, Colorado
- +20 more
Dec 5, 2021
Stage III Breast Cancer, Stage IIIA Breast Cancer, Stage IIIB Breast Cancer Trial in Nashville (Atezolizumab, Cobimetinib,
Terminated
- Stage III Breast Cancer
- +6 more
- Atezolizumab
- +2 more
-
Nashville, TennesseeVanderbilt-Ingram Cancer Center
Aug 10, 2021
Leukemia, Myeloid, Acute Trial in Worldwide (Cobimetinib, Idasanutlin, Venetoclax)
Completed
- Leukemia, Myeloid, Acute
- Cobimetinib
- +2 more
-
Los Angeles, California
- +16 more
Dec 13, 2021
Leukemia, Myeloid, Acute Trial in Worldwide (Cytarabine, Idasanutlin, Placebo)
Non-Hodgkin's Lymphoma Trial in Worldwide (Idasanutlin, Obinutuzumab, Rituximab)
Terminated
- Non-Hodgkin's Lymphoma
- Idasanutlin
- +2 more
-
Phoenix, Arizona
- +23 more
Apr 29, 2020
Solid Tumors Trial in Canada, United States (Idasanutlin)
Completed
- Solid Tumors
- Idasanutlin
-
Aurora, Colorado
- +10 more
Jun 18, 2019
Solid Tumors Trial in Budapest (Idasanutlin, Placebo, [13C]-radiolabeled Idasanutlin)
Completed
- Solid Tumors
- Idasanutlin
- +3 more
-
Budapest, HungaryMagyar Honvedseg Egeszsegugyi Kozpont
Dec 14, 2017